Recorded Chinese product: 氯膦酸二钠片氯膦酸二钠片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 南京制药厂有限公司Chinese legal name: 南京制药厂有限公司
主要成分Active Ingredients
- 氯屈膦酸二钠Lvqu Linsuan Erna
药物知识说明
氯屈膦酸二钠是一种在国家药监局注册认定的药品。该药品含有氯屈膦酸二钠-1e568249等成分。
该药品关联的活性成分包括：氯屈膦酸二钠Lvqu Linsuan Erna。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：南京制药厂有限公司Chinese legal name: 南京制药厂有限公司。
您可以探索含有相同成分的其他药品：氯屈膦酸二钠-1e568249成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 氯膦酸二钠片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 氯屈膦酸二钠Lvqu Linsuan Erna.
Manufacturers recorded for this product: 南京制药厂有限公司Chinese legal name: 南京制药厂有限公司.
Explore other medicines containing the same ingredient: 氯屈膦酸二钠 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 氯膦酸二钠片Recorded Chinese product: 氯膦酸二钠片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 0.2g(按CH2Cl2Na2O6P2计)Recorded Chinese specification
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 南京制药厂有限公司Chinese legal name: 南京制药厂有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H19980058
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H19980058
Manufacturer
Chinese legal name: 南京制药厂有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H19980058
生产企业
南京制药厂有限公司(国产)
适应症
1.恶性肿瘤并发的高钙血症。|2.溶骨性癌转移引起的骨痛。|3.可避免或延迟恶性肿瘤溶骨性骨转移。|4.各种类型骨质疏松。
用法用量
1.Paget病：300mg/日，静脉滴注3小时以上，共5日，以后改口服。|2.高钙血症：300mg/日，静脉滴注3~5日或一次给予1.5g静脉滴注，血钙正常后改口服。
不良反应
1.少数情况下会出现眩晕和疲劳，但往往随治疗的继续而消失。|2.有时可出现血清乳酸脱氢酶等肝酶水平升高，白细胞减少及肾功能异常等不良反应。
禁忌
1.对本品过敏者禁用。|2.严重肾损害者、骨软化症患者禁用。
注意事项
1.用于治疗骨质疏松症时，应遵医嘱决定是否需要补钙。如需要补钙，本品与钙剂应分开应用，用本品后2小时再用钙剂，以免影响本品的吸收，降低疗效。|2.用药期间，对血细胞数、肾脏和肝功能应进行监测。
贮藏
不要贮藏于25℃以上。将所有药物置于儿童不能触及处。
规格
0.2g(按CH2Cl2Na2O6P2计)
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.